Results 201 to 210 of about 217,258 (295)

c-Abl Kinase Targets Tight Junction Protein ZO-2 in Regulation of Cell Migration and Morphology. [PDF]

FASEB J
Choi DE, Gweon B, Notbohm J, Kim H, Liu XS, Fredberg JJ.   +5 more
europepmc   +1 more source

Crk and Abi1: Binary Molecular Switches That Regulate Abl Tyrosine Kinase and Signaling to the Cytoskeleton [PDF]

, 2012
S. M. Zakir Hossain, Patrycja M. Dubielecka, Aleksander F. Sikorski, Raymond B. Birge, Leszek Kotula   +4 more
openalex   +1 more source

Idealized Offshore Low‐Level Jets for Turbine Structural Impact Considerations

Wind Energy, Volume 29, Issue 2, February 2026.
ABSTRACT Low‐level jets (LLJs) describe conditions in which the wind speed reaches a local maximum with respect to altitude near the surface; they have been observed intermittently in the US mid‐Atlantic offshore environment. LLJs pose unique operating conditions for future wind turbines operating in the region, such as negative shear and locally ...
Emily de Jong, Eliot Quon, Daniel Zalkind   +2 more
wiley   +1 more source

Exosome and BCR-ABL mediated molecular alterations in endothelial cells in chronic myeloid leukemia: identification of seven genes and their regulatory network. [PDF]

PeerJ
Shen Z, Cao H, Zhou Y, Mao W, Liu K, Zhu J, He M, Mao Y, Luo N, Feng L, Le H, Song L, Li H, Yousafzai YM, Zia A, Gu X, Zhang S.   +16 more
europepmc   +1 more source

Real‐world evidence of tirbanibulin in the treatment of actinic keratosis in Germany – prospective, multicenter, non‐interventional KLIR study

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 2, Page 186-193, February 2026.
Summary Background Tirbanibulin is an approved topical treatment for actinic keratosis (AK). This non‐interventional study investigated effectiveness and safety of tirbanibulin for AK. Patients and Methods The prospective KLIR‐study was conducted at 58 German dermatology centers (02/2022–09/2023).
Markus V. Heppt, Ina Hadshiew, Afra Kempf, Antje Melzer, Carola Berking   +4 more
wiley   +1 more source

Specificity of dermatological adverse events of BCR-ABL tyrosine kinase inhibitors and their effect on quality of life of patients with chronic myeloid leukemia

, 2020
Е. А. Шатохина, Anna Turkina, Ekaterina Chelysheva, Oleg Shukhov, Anna Petrová, А. М. Ковригина, Л. С. Круглова, E. V. Ranenko, P. G. Nosikova   +8 more
openalex   +2 more sources

Distinct endothelial cell toxicities of Abl tyrosine kinase inhibitors lead to arterial thrombosis. [PDF]

Blood Vessel Thromb Hemost
Travers R, Stepanian A, Redford S, Martin G, Svedberg NL, Xu K, Merrill-Skoloff G, Chen C, Flaumenhaft R, Jaffe IZ.   +9 more
europepmc   +1 more source

Stem cells in chronic myeloid leukaemia [PDF]

, 2007
Holyoake, T., Pellicano, F.
core   +1 more source

Entre a aposentadoria e a morte: Oliveira Vianna nos salões da ABL e nas páginas do jornal <i>Letras Fluminenses</i>

George Leonardo Seabra Coelho
openalex   +2 more sources

Response Assessment of Generic Tyrosine Kinase Inhibitors in Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase: A Prospective Study from a Tertiary Care Centre in North Eastern India. [PDF]

Cureus
Choudhuri A, Bhattacharyya J, Das S, Das D, Dhameja N.   +4 more
europepmc   +1 more source